Journal article
Long-term treatment with dalteparin low-molecular-weight heparin (LMWH) may improve survival in patients with non-metastatic malignancy and venous thromboembolism (VTE)
Authors
Lee AYY; Julian JA; Levine MN; Baker RI; Bowden C; Kakkar AK; Prins M; Rickles FR; Gent M
Journal
Journal of Thrombosis and Haemostasis, Vol. 1, , pp. oc004–oc004
Publisher
Elsevier
Publication Date
July 1, 2003
DOI
10.1111/j.1538-7836.2003.tb03300.x
ISSN
1538-7933